Your browser doesn't support javascript.
loading
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance.
Lamballe, Fabienne; Ahmad, Fahmida; Vinik, Yaron; Castellanet, Olivier; Daian, Fabrice; Müller, Anna-Katharina; Köhler, Ulrike A; Bailly, Anne-Laure; Josselin, Emmanuelle; Castellano, Rémy; Cayrou, Christelle; Charafe-Jauffret, Emmanuelle; Mills, Gordon B; Géli, Vincent; Borg, Jean-Paul; Lev, Sima; Maina, Flavio.
Afiliación
  • Lamballe F; Aix Marseille Univ CNRS Developmental Biology Institute of Marseille (IBDM) Turing Center for Living Systems Parc Scientifique de Luminy Marseille 13009 France.
  • Ahmad F; Aix Marseille Univ CNRS Developmental Biology Institute of Marseille (IBDM) Turing Center for Living Systems Parc Scientifique de Luminy Marseille 13009 France.
  • Vinik Y; Department of Molecular Cell Biology Weizmann Institute of Science Rehovot 76100 Israel.
  • Castellanet O; Aix Marseille Univ CNRS Developmental Biology Institute of Marseille (IBDM) Turing Center for Living Systems Parc Scientifique de Luminy Marseille 13009 France.
  • Daian F; Aix Marseille Univ CNRS Developmental Biology Institute of Marseille (IBDM) Turing Center for Living Systems Parc Scientifique de Luminy Marseille 13009 France.
  • Müller AK; Department of Molecular Cell Biology Weizmann Institute of Science Rehovot 76100 Israel.
  • Köhler UA; Department of Molecular Cell Biology Weizmann Institute of Science Rehovot 76100 Israel.
  • Bailly AL; Aix Marseille Univ Centre de Recherche en Cancérologie de Marseille (CRCM) Equipes labellisées Ligue 'Cell polarity, cell signaling and cancer' and 'Telomere and Chromatin' Inserm CNRS Institut Paoli-Calmettes Marseille 13009 France.
  • Josselin E; Aix Marseille Univ Inserm CNRS Institut Paoli-Calmettes CRCM TrGET Platform Marseille 13009 France.
  • Castellano R; Aix Marseille Univ Inserm CNRS Institut Paoli-Calmettes CRCM TrGET Platform Marseille 13009 France.
  • Cayrou C; Aix Marseille Univ Centre de Recherche en Cancérologie de Marseille (CRCM) Equipes labellisées Ligue 'Cell polarity, cell signaling and cancer' and 'Telomere and Chromatin' Inserm CNRS Institut Paoli-Calmettes Marseille 13009 France.
  • Charafe-Jauffret E; Aix Marseille Univ Inserm CNRS Institut Paoli-Calmettes CRCM Experimental Histo-Pathology Platform Marseille 13009 France.
  • Mills GB; Knight Cancer Institute Portland OR 97201 USA.
  • Géli V; Aix Marseille Univ Centre de Recherche en Cancérologie de Marseille (CRCM) Equipes labellisées Ligue 'Cell polarity, cell signaling and cancer' and 'Telomere and Chromatin' Inserm CNRS Institut Paoli-Calmettes Marseille 13009 France.
  • Borg JP; Aix Marseille Univ Centre de Recherche en Cancérologie de Marseille (CRCM) Equipes labellisées Ligue 'Cell polarity, cell signaling and cancer' and 'Telomere and Chromatin' Inserm CNRS Institut Paoli-Calmettes Marseille 13009 France.
  • Lev S; Institut Universitaire de France (IUF) 1 rue Descartes Paris 75231 France.
  • Maina F; Department of Molecular Cell Biology Weizmann Institute of Science Rehovot 76100 Israel.
Adv Sci (Weinh) ; 8(3): 2003049, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33552868

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Adv Sci (Weinh) Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Adv Sci (Weinh) Año: 2021 Tipo del documento: Article